ADNI data is made available to researchers around the world. As such, there are many active research projects accessing and applying the shared ADNI data. To further encourage Alzheimer’s disease research collaboration, and to help prevent duplicate efforts, the list below shows the specific research focus of the active ADNI investigations. This information is requested annually as a requirement for data access.
| Principal Investigator | |
| Principal Investigator's Name: | Lori Daiello |
| Institution: | Brown University/Rhode Island Hospital |
| Department: | Neurology |
| Country: | |
| Proposed Analysis: | I propose to explore the relationships between pharmacotherapy and MRI brain volumes over time in the ADNI cohort |
| Additional Investigators | |
| Investigator's Name: | Brian Ott |
| Proposed Analysis: | The planned primary analysis will examine the association between pharmacotherapy, cognition, and brain volume in the ADNI cohort. Due to various delays, the project was commenced on July 2010. The final datasets are being prepared, IRB approval is being sought, and the analyses should be completed before December 2010. |
| Investigator's Name: | Ronald Cohen |
| Proposed Analysis: | The planned primary analysis will examine the association between pharmacotherapy, cognition, and brain volume in the ADNI cohort. Due to various delays, the project was commenced on July 2010. The final datasets are being prepared, IRB approval is being sought, and the analyses should be completed before December 2010. |
| Investigator's Name: | Shira Dunsiger |
| Proposed Analysis: | The planned primary analysis will examine the association between pharmacotherapy, cognition, and brain volume in the ADNI cohort. Due to various delays, the project was commenced on July 2010. The final datasets are being prepared, IRB approval is being sought, and the analyses should be completed before December 2010. |
| Investigator's Name: | Win Gongtavana |
| Proposed Analysis: | The planned primary analysis will examine the association between pharmacotherapy, cognition, and brain volume in the ADNI cohort. Due to various delays, the project was commenced on July 2010. The final datasets are being prepared, IRB approval is being sought, and the analyses should be completed before December 2010. |